Escobar Mauricio A, Jay Colleen L, Brooks Ronald M, West Karen W, Rescorla Frederick J, Molleston Jean P, Grosfeld Jay L
Section of Pediatric Surgery, Department of Surgery, the JW Riley Hospital for Children, Indianapolis, IN 46202, USA.
J Pediatr Surg. 2006 Jan;41(1):99-103; discussion 99-103. doi: 10.1016/j.jpedsurg.2005.10.072.
This study tests the hypothesis that steroid administration improves the outcome of biliary atresia (BA) by evaluating the efficacy of postoperative steroid use on surgical outcomes in infants with BA.
Steroid use and outcomes in patients with BA were retrospectively analyzed at a tertiary pediatric hospital. Institutional review board approval was obtained.
Kasai portoenterostomy (PE) was performed in 43 patients with BA treated from 1992 to 2004 (16 boys and 27 girls). Twenty-one PE patients received steroids and 22 did not. Portoenterostomy was successful in 24 patients (55.8%) with consistent serum bilirubin less than 2 mg/dL. Sixteen (66%) received postoperative steroids. A normal postoperative bilirubin was achieved at 6 months in 16 (76%) of 21 patients with steroids compared with 8 (37%) of 22 in untreated controls (Fisher's Exact test, P = .01). Of the 43 patients, 19 (44%) required liver transplantation, including 7 (37%) of 19 with steroids vs 12 (63%) of 19 without (P = .2). Twenty-eight infants developed cholangitis (fever with and without changes in hepatic function): 25 after PE and 3 after transplant. Of the 25, 12 (48%) received steroids. Seven died (16%) (range, 7 months to 4 years): 2 while awaiting transplantation (received steroids) and 5 after transplantation (1 received steroids and 4 were untreated). Survival was 86% (18/21) in patients with steroids and 82% (18/22) in those without. Transplant survival (74%) was comparable to previously reported historical controls (82%).
The Kasai PE continues to be the procedure of choice in infants with BA younger than 3 months. A significantly improved clearance of postoperative jaundice and lower serum bilirubin levels were observed in patients receiving steroids. However, steroids had no effect on the incidence of cholangitis, need for liver transplantation, and overall survival. A prospective study with standardized dose and length of steroid administration and longer period of follow-up is necessary to more accurately assess the effectiveness of steroids after PE.
本研究通过评估术后使用类固醇对胆道闭锁(BA)患儿手术结局的疗效,检验类固醇给药可改善BA预后的假设。
在一家三级儿科医院对BA患者的类固醇使用情况及结局进行回顾性分析。获得了机构审查委员会的批准。
1992年至2004年期间,对43例接受治疗的BA患者进行了Kasai肝门肠吻合术(PE)(16例男孩,27例女孩)。21例PE患者接受了类固醇治疗,22例未接受。24例患者(55.8%)的肝门肠吻合术成功,血清胆红素持续低于2mg/dL。16例(66%)接受了术后类固醇治疗。21例接受类固醇治疗的患者中,16例(76%)在6个月时术后胆红素恢复正常,而未治疗的对照组22例中有8例(37%)恢复正常(Fisher精确检验,P = 0.01)。43例患者中,19例(44%)需要肝移植,其中接受类固醇治疗的19例中有7例(37%),未接受治疗的19例中有12例(63%)(P = 0.2)。28例婴儿发生胆管炎(伴有或不伴有肝功能变化的发热):25例在PE术后发生,3例在移植后发生。在这25例中,12例(48%)接受了类固醇治疗。7例死亡(16%)(年龄范围为7个月至4岁):2例在等待移植期间死亡(接受了类固醇治疗),5例在移植后死亡(1例接受了类固醇治疗,4例未接受治疗)。接受类固醇治疗的患者生存率为86%(18/21),未接受治疗的患者生存率为82%(18/22)。移植生存率(74%)与先前报道的历史对照组(82%)相当。
Kasai PE仍然是3个月以下BA婴儿的首选手术方式。接受类固醇治疗的患者术后黄疸清除明显改善,血清胆红素水平降低。然而,类固醇对胆管炎的发生率、肝移植需求和总体生存率没有影响。有必要进行一项前瞻性研究,规范类固醇给药的剂量和疗程,并延长随访时间,以更准确地评估PE术后类固醇的有效性。